Product Information
BUSPIRONE HCL 30 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1117 per EA under NDC 16729028912. Its NADAC has been published 490 times since Jan 4, 2017.
Strength
30 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729028912
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202557On Market Since
12/15/2016
Price Statistics
The NADAC for BUSPIRONE HCL 30 MG TABLET has been published 490 times since Jan 4, 2017, and over the history we have for it it has declined 78.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1117 per EA |
|---|---|
| All-time high | $0.5144 (Jan 11, 2017) |
| All-time low | $0.0971 (May 22, 2024) |
| 52-week high | $0.1235 |
| 52-week low | $0.1098 |
| Median price | $0.2257 |
| Average price | $0.2280 |
| Largest weekly change | +36.0% (Jun 19, 2024) |
| Weeks tracked | 490 |
| Tracking since | Jan 4, 2017 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 30 MG TABLET, manufactured by Accord Healthcare Inc., is $0.1117 per EA (NDC 16729028912), effective May 20, 2026.
How has the price of BUSPIRONE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 30 MG TABLET has declined 78.3%. It has been tracked across 490 weekly CMS publications since Jan 4, 2017.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 30 MG TABLET?
Since Jan 4, 2017, the NADAC for BUSPIRONE HCL 30 MG TABLET has ranged from a low of $0.0971 (May 22, 2024) to a high of $0.5144 (Jan 11, 2017), with a median of $0.2257 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 30 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as BUSPIRONE HCL 30 MG TABLET, but none are currently priced below it.
Who manufactures BUSPIRONE HCL 30 MG TABLET?
BUSPIRONE HCL 30 MG TABLET (NDC 16729028912) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification